Anti-neuropathic pain activity of Ajugarin-I via activation of Nrf2 signaling and inhibition of TRPV1/TRPM8 nociceptors in STZ-induced diabetic neuropathy
- 5 August 2022
- journal article
- research article
- Published by Elsevier in Pharmacological Research
- Vol. 183, 106392
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Natural Products Evaluated in Neuropathic Pain Models ‐ A Systematic ReviewBasic & Clinical Pharmacology & Toxicology, 2013
- Dietary Iron Concentration May Influence Aging Process by Altering Oxidative Stress in Tissues of Adult RatsPLOS ONE, 2013
- Molecular mechanism of capillarisin-mediated inhibition of MyD88/TIRAP inflammatory signaling in in vitro and in vivo experimental modelsJournal of Ethnopharmacology, 2013
- Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic NephropathyDiabetes, 2011
- Oxidative stress and Nrf2 in the pathophysiology of diabetic neuropathy: Old perspective with a new angleBiochemical and Biophysical Research Communications, 2011
- Protective effects of enalapril in streptozotocin‐induced diabetic rat: studies of DNA damage, apoptosis and expression of CCN2 in the heart, kidney and liverJournal of Applied Toxicology, 2011
- Anti-inflammatory effect of Ajuga bracteosa Wall Ex Benth. mediated through cyclooxygenase (COX) inhibitionJournal of Ethnopharmacology, 2011
- The Role of The TRPV1 Endogenous AgonistN-Oleoyldopamine in Modulation of Nociceptive Signaling at the Spinal Cord LevelJournal of Neurophysiology, 2009
- Hippocampal neurodegeneration in experimental autoimmune encephalomyelitis (EAE): potential role of inflammation activated myeloperoxidaseMolecular and Cellular Biochemistry, 2009
- Differential expression of the capsaicin receptor TRPV1 and related novel receptors TRPV3, TRPV4 and TRPM8 in normal human tissues and changes in traumatic and diabetic neuropathyBMC Neurology, 2007